The Unlikely Duo: Alzheimer’s Disease and Type II Diabetes

Most people’s first thoughts are that there is no connection between Alzheimer’s disease and type II diabetes. Years ago that may have been true, but research today proves otherwise. In fact, people with type II diabetes are more likely to develop Alzheimer’s, and vice versa. More than 30 million people in the United States have diabetes – about 1 in 10 people. Between 90% and 95% of people with diabetes have type II diabetes. About 5.8 million people, of all ages, in the United States have Alzheimer’s. Roughly 1 in 10 people over the age of 65 has this disease. Alzheimer’s disease is the sixth-leading cause of death in the United States.

What is Alzheimer’s Disease?

Alzheimer’s Disease (AD) is a type of dementia that effects memory, thinking, and behavior. AD usually occurs in old age, most people being over 65, but it can occur in younger people (early-onset Alzheimer’s). It is a progressive disease where symptoms become worse over time. This disease is only diagnosable post-mortem (after death).

               What is going on in the brain?

Though it is unknown exactly how AD starts, scientists do know two major abnormal structures that play a role in the pathology of the disease. The first are the presence of beta-amyloid plaques. These plaques are build-ups of the protein fragment, beta-amyloid. The second indicator is the presence of neurofibrillary tangles. These tangles are twisted fibers of the tau protein.

What is Type II Diabetes?

Type II diabetes (T2D) occurs when cells in the body, including in the brain, do not respond normally to insulin. Insulin is a hormone secreted by the pancreas to help regulate glucose (blood sugar) levels. Cells need glucose for energy. Normally, cells willingly take up glucose with the help of insulin. In T2D, cells don’t respond to the insulin, therefore not taking up glucose. This is called insulin resistance. Since glucose doesn’t enter the cells, the pancreas secretes more and more insulin until it eventually can’t keep up. Why T2D occurs is unknown but there are some risk factors including being overweight, fat distribution, inactivity, age, etc.

How are they connected?

Brains Chained by Addiction

The Pandemic of Addiction

The statistics surrounding addiction don’t lie, the U.S. has a pandemic on its hands. So what’s the situation?

In 2017, we saw a 9.6% increase in overdose deaths in the U.S. from 2016. That is a near ten percent jump in just one year. This isn’t a new issue. Also according to the CDC,  “During 2008–2011, an average of 1.1 million emergency department (ED) visits were made each year for drug poisoning, with a visit rate of 35.4 per 10,000 persons. Poisoning is the leading cause of injury-related mortality in the United States, with more than 40,000 deaths annually. Drugs account for 90% of poisoning deaths, and the number of deaths from drug poisoning has increased substantially in recent years.

If you’re interested in digging deeper, here’s the link to the CDC’s website, where the above statistics were taken from. If a quick video interview is more your style, check on the short video below.

Continue reading →

Is addiction a choice?

 

Addiction is a complex problem with many people disagreeing on what it is, how to treat it, and how addicts should be treated or not treated. One of the most hot button topics is whether addiction is a choice or not and by default, the fault of the person addicted. Let’s discuss the two sides and then look at what the science tells us.

 

Those who argue that addiction is a choice say that the individual made the first choice to ingest the drug and the consequences fall on their shoulders for what follows. Some may even say that those who are “psychologically weak” are the ones who get addicted and those who may be “psychologically stronger” could quit the drug whenever they wanted.

On the other hand, those who think addiction is not a choice may contend that while yes, the individual made the choice to ingest the drug, there may be other circumstances that led to that decision. Perhaps they were dealing with mental health issues and felt the need to self-medicate or were pressured by their friends. Additionally, people on this side of the issue often point to the horrible effects of chronic drug use and the torture of withdrawal to argue that no one would consciously choose that for themselves.

What’s the science behind it?

Now that we know some the aspects of public perception, let’s look at what the science supports.

 

Within our brain, there is something called the reward pathway. When this pathway is activated, it generates pleasurable emotions and also activates motivation systems that increase desire for that pleasurable feeling. Drugs like meth, cocaine, and opioids, stimulate parts of this pathway like the ventral tegmental area and the nucleus accumbens with an excess amount of dopamine compared to our everyday stimuli. Dopamine is a neurotransmitter that controls our reaction and feelings of pleasure. When people don’t take the drug, their body begins to crave that pleasurable feeling given by the drug since the body has become accustomed to the higher levels of dopamine produced by the drug.

Let’s use meth as an example to see how this pathway works. Meth can inter a neuron and replace dopamine causing it to be pushed out into the cell. Similarly, the drug can also block the re-uptake of excess dopamine back into the neuron. Both of these interactions increase the amount of dopamine in the synapse leading to that pleasurable feeling.

However, this pleasurable feeling given by the excess of dopamine creates a craving for more in the brain when meth is not being used. The everyday levels of dopamine given off are no longer enough because the synapse has changed to accommodate the increase of dopamine. Not only is our body craving dopamine, but other downstream factors have been altered.  When there is an excess of firing from dopamine receptors, there is increased phosphorylation of CAMP which then leads to the expression of immediate early genes (IEG) like c-fos. These IEG’s start a cascade of other events that may form addictive behavior as well as molecular changes that lead to synaptic plasticity and long term potentiation. Essentially, after becoming addicted to drugs, the systems in your brain physically change making it harder and harder for you to quit.

So is it a choice or not?

Therefore, the actual process of becoming addicted to a drug is not a choice. Individuals may disagree on the importance of personal responsibility of first ingesting the drug but there is no scientific disagreement on the strength of the biological processes that addiction creates. Your brain has been physically altered, there is no “psychologically strong” or “psychologically weak” because all our brains can become victim to this process. If you are interested in learning more about addiction and it’s effects, visit https://www.samhsa.gov/public-messages

Party in the Cleft

Evolutionarily, humans have been wired to perceive feelings of pleasure based on certain stimuli that are associated with survival of the individual or species. Stimuli that evoke this reward system include sexual pleasure, foods, drinks, and success to list a few. Stimuli activate the mesolimbic dopamine pathway which originates in the ventral tegmental area (VTA). When VTA neurons are activated, dopamine release is increased at the synaptic cleft of the nucleus accumbens (NA). Both the NA and the VTA are associated with motivation due to the long-term potentiation that occurs. Under natural stimuli, dopamine is invited to the cleft tea time party and leaves after a short while. However, humans have found and developed different more intense ways to satisfy the reward system that aren’t natural “survival stimuli.” The use of drugs.

Drugs activate the same reward pathway which is a large proponent of their addictive nature. Mainly, drugs act to increase dopamine and other neurotransmitters in the synaptic cleft of the NA to induce the feelings of pleasure. Dopamine causes D1 receptors to fire action potentials which then begins a signal cascade in the neurons. If neurons are fired regularly, AMPA receptors increase in number and become more active which leads to long term potentiation and memory formation. Continual use also changes the size and shape of neurons. Once neurons change, they are unlikely to return to the original form.

NIDA-NIH

Increasing dopamine and other neurotransmitters in the cleft can be achieved in many ways and therefore is variable for different drugs. Below are a few commonly used drugs and how they increase dopamine in the cleft.

  • Cocaine inhibits the re-uptake of dopamine, allowing the dopamine to act for a longer period of time at higher concentrations.
  • Opioids inhibit GABA which inhibits dopamine, therefore increasing dopamine activity.

Cocaine and opioids are addictive because of the increased D1 activation that induces a signal cascade resulting in synaptic plasticity, memory formation in the motivation centers.

In the recruitment of dopamine and norepinephrine to the cleft party, cocaine and opioids are sorely incompetent compared to methamphetamine. Cocaine and opioids throw an intimate slumber party with only their closest friends while methamphetamine invites the whole college campus and advertises free root beer at a weekend long music festival.

  • Methamphetamine induces the release of dopamine in four different ways, induces the release of norepinephrine in two ways, blocks re-uptake of the neurotransmitters, and blocks their degradation.

For this reason, methamphetamine is highly addictive and difficult to quit. Even small amounts of methamphetamine cause massive recruitment of neurotransmitters. The neurotransmitters induce the same signaling pathway through D1 receptors and leads to the expression of genes that are associated with addictive behaviors. Some of these genes encode proteins that are further involved in long term potentiation and learning, such as in the case for delta FosB. These processes cause damage to the synapse that can never fully be repaired.

Therefore, methamphetamine addiction should be avoided at all costs or treated early on. Even early treatment may not be enough to reverse the damage that has been done. Though these drugs provide incredible rewards for an individual, their temporary effects are not worth the lifelong consequences.

Schizophrenia: Reality vs Stigma

Schizophrenia: What is it and how do we treat it?

Schizophrenia is one of the most challenging mental illnesses to manage and function with. Symptoms often interfere with reality, having a significant impact on relationships and a person’s ability to function within the “normal” expectations of society. First, for a quick one-minute overview, check out this video from the National Alliance on Mental Health.

Medications, which are typically antipsychotics, are far from perfect, or even decent; the side effects are horrendous and can be permanent, many medications don’t work well or only treat certain symptoms, and constant dose adjustments must be made to maximize efficiency while limiting negative effects. Due to these problems, many patients with schizophrenia refuse to stay on their medications, raising difficult questions for family members and physicians. Check out this website from the Mayo Clinic for some basic information about schizophrenia and its treatments.

Continue reading →

Sugar on the Brain: Alzheimer’s Disease

What’s the story?

Over the past decade, sugar has become an increasingly hot topic as a part of our diets. Updated recommendations have been in the news as recent as two days ago, which you can check out here.

Various cities and states have  implemented (or tried to implement) sugary drink taxes to try and curb their populations’ never ending enthusiasm for these addictive sugar-laden foods. Many of the consequences of very high sugar intake are well known, like weight gain and type II diabetes. However, what a lot of people don’t know is how tightly linked diabetes and the development of Alzheimer’s are.

 

However, what a lot of people don’t know is how tightly linked diabetes and the development of Alzheimer’s are.

 

According to Mayo Clinic, a variety of studies have linked Alzheimer’s disease with diabetes, especially type two diabetes. While some studies are inconclusive and the mechanisms are poorly understood, there is certainly some connection between insulin signaling in the brain and the development of Alzheimer’s disease. In fact, many people with diabetes have changes in the brain that are indicative of both Alzheimer’s disease and vascular dementia. This may also contribute to the symptoms being seen, separate from an Alzheimer’s diagnosis. If you want to read more, here’s the article.

Continue reading →

Stressful Memory Formation: Nature, Nurture, Notion

What really goes on in your brain when you experience a stressful event? And the memories that are formed, what makes them shift from a helpful reminder of a trepidatious situation to a triggering event? These are questions that neuroscientists are asking about memories formed after stressful events. While it seems obvious that stress is a part of human life and remembering past events contributes to learning and success in our futures, there are some stressful events that create memories upon whose recall manifests as anxiety or PTSD symptoms. Are these memories a coping mechanism for dealing with extreme stress and trauma, or do they exacerbate the trauma such that it adversely affects someone’s life experience long after the fact?

 

The molecular pathway outlined in Reul’s article involves a stress hormone stimulus that causes a protein to be modified in such a way that it allows two genes to be transcribed. These genes code for proteins that are important for the growth of neurons and memory consolidation. In a stressful situation, these genes are transcribed in higher amounts, allowing for a stressful event to be recorded and remembered in the brain. If a more anxious person experiences a stressful event, more proteins are synthesized, and the memory consolidation is stronger.

 

Here are three proposed molecular differences in brains that experience stressful events and develop stress-related disorders and brains that do not:

  1. Epigenetics: the differing expression of genes related to external stimulation. Genetic predisposition to stress-related disorders (including PTSD and general anxiety) are implicated in studies showing that the same stressful experiences are recorded differently in the brain. While many people experience extreme stress in their lives, only between 10-20% of them develop a stress-related disorder.[1]
  2. GABA: the brain’s primary inhibitory neurotransmitter. When a lot of GABA is present in the dentate gyrus, there is less of an anxious response to a stressful situation: the molecular pathway outlined above is inhibited. Congruently, increased excitability of neurons leads to higher expression of memory consolidation genes.
  3. Hippocampus: the emotion processor involved with memory formation. A region of the hippocampus is important for the integration of emotional and cognitive data. When this area is functioning improperly, learning and memory are impaired. Additionally, the interplay between this region and the amygdala leads to decreased memory storage in the dentate gyrus. The lack of memory formation would directly affect the chance that someone who experiences a stressful event would remember it or develop a stress-related disorder.

 

It’s definitely a tricky situation with lots of interplay between genetic make-up, individual environment, and so many other factors that we as scientists do not understand and we as humans simply have to live with and help each other to live with.

[1] Reul, Johannes M.J.M. 2014. Making memories of stressful events: a journey along epigenetic, gene transcription, and signaling pathways. Frontiers in Psychiatry 5(5):1-11.

Alzheimer’s Disease: A Manifestation of Type II Diabetes on the Brain?

With current research enlightening a link between Type II Diabetes and the development of Alzheimer’s Disease through many mechanisms and risk factors, the role of insulin in the pathologies of both conditions is becoming a hot topic in medicine. Type II Diabetes increases the risk factor of developing dementia by two, and according to a 2004 study, the risk of developing Type II Diabetes is higher in Alzheimer’s patients.[1] Since the risk of developing either disease goes both ways, it is important to explore the big picture ways each disease advances and their overlap.

 

Insulin is a hormone that is synthesized in the pancreas, and has long been associated with Type II Diabetes. In a healthy system, insulin is released from the pancreas following a rise in blood sugar levels (after eating), and can bind to insulin receptors on a variety of cells throughout our bodies including fat, liver, muscles and even brain cells. The cellular pathways initiated by insulin binding to its receptors are myriad: they can have downstream effects as different as sugar storage and cell growth, among others.[2]

 

However, since the discovery of insulin receptors in the brain, scientists have investigated many more functions of insulin. Fascinatingly, insulin has been shown to play a role in protection of neurons, aiding with neuronal growth and survival, improving verbal memory and selective attention in healthy humans (Vieira et al., 2017). Most pertaining to Alzheimer’s is the implication of insulin in gene expression related to long term memory.

 

This crazy, tiny hormone does so many things for our bodies! It is chilling to think about what happens when insulin signalling goes wrong. When these signalling pathways do not get initiated the way they are supposed to (by insulin), we say that the system is exhibiting insulin resistance.

 

Both Alzheimer’s Disease and Type II Diabetes display insulin resistance as a primary molecular mechanism that leads to their development and worsening, but it is difficult to decide what really causes insulin resistance, and therefore what causes either disease. Many potential starting points have been proposed and are plausible: it is almost as if insulin resistance is cyclical, and we are jumping on to the mechanistic wheel in the middle of the disease propagation regardless of where we start.

 

After briefly examining the overlap between Type II Diabetes and Alzheimer’s, serious questions must be asked of the current health care system and its ability to provide effective and accessible healthcare to those living with Type II Diabetes and Alzheimer’s. The inventors of synthetic insulin sold their patent for only one dollar, with the intention that everyone who should need the drug would have access to it. Unfortunately, their desire to make their insulin accessible and affordable is not a reality, with the price of insulin nearly tripling within ten years (2002 to 2013). At a standard price of 480$ per vial, each of the 30 million Americans experiencing diabetes can pay thousands of dollars per year to get enough insulin to survive. If insulin mediation and other treatments for Type II Diabetes might be effective treatments for Alzheimer’s, as Vieira’s review article suggests, then the disadvantaged population has increased by almost 6 million.[3] Further, if Type II Diabetes and Alzheimer’s both play roles in the development of the other, then effective and affordable education and management options for Type II Diabetes are necessary to reduce the risk of Alzheimer’s, a brutal and debilitating disease.

[1]Vieira MNN, Lima-Filho RAS, De Felice FG. 2017. Connecting Alzheimer’s disease to diabetes: Underlying mechanisms and potential therapeutic targets. Neuropharmacology 136(2018):160-171.Neurochem Artstract 1Neurochem Artstract 1

[2] Vieira MNN, Lima-Filho RAS, De Felice FG. 2017. Connecting Alzheimer’s disease to diabetes: Underlying mechanisms and potential therapeutic targets. Neuropharmacology 136(2018):160-171.

[3] https://www.alz.org/alzheimers-dementia/facts-figures

Schizophrenia: Misconceptions and a Journey to Diagnosis

Imagine going through your life as a healthy kid, both physically and mentally, and then one day everything changes. You start to hear voices from people who are not visually present – you start to hallucinate – and you develop an intense distrust of people you have interacted with and had relationships with for years. Schizophrenia does not look like this for everyone and not everyone has a sudden onset of symptoms, but these occurrences are very common with many people living with schizophrenia.

 

A Journey to Being Diagnosed with Schizophrenia

Tanara was diagnosed with Schizophrenia at 27, but the years leading up to that diagnosis were not easy. Five years prior to her diagnosis, Tanara developed symptoms of paranoia, hallucinations, and hearing voices. These symptoms persisted, and the next year she was hospitalized, followed by being given series of medications. Her symptoms stopped, and she thought everything was back to normal. This cycle of symptoms, medication, and a seemingly resolved mood disorder happened again over the next two years or so. Then, a breaking point led to her diagnosis with Schizophrenia.

Tanara lost her grandmother and suffered a hysterical breakdown, followed by being jailed over a fight with a neighbor. She was ordered to go to a psychiatric hospital where she was diagnosed with schizophrenia. From then on, she began a medication regimen and therapy to learn about and cope with her symptoms, and from there she began to take back control over her life.

Now, Tanara has a job where she is thriving, and she is more hopeful than ever about her future. Being able to recognize her triggers and knowing that schizophrenia doesn’t define her is crucial for her continued success. (To read Tamara’s full story, click here.)

 

Misconceptions about Schizophrenia

“People with schizophrenia are always dangerous.”

Reality: It is rare for people with schizophrenia to be violent. Actually, people with schizophrenia are more often victims of violence than the ones committing violent crimes.

“People with schizophrenia need to be in a hospital.”

Reality: Modern treatment methods are a combination of (but not limited to) medication prescriptions, out-patient therapy, and various lengths of hospitalization.

“Bad parenting causes schizophrenia.”

Reality: There is no evidence that parenting methods have an effect on the chances of developing schizophrenia. Genetics, however, do come into play in the chances of developing schizophrenia.

“Schizophrenics have multiple personalities.”

Reality: While a confusion of reality and fantasy may happen, multiple personalities are not part of the schizophrenia diagnosis.

You can read more about the misconceptions about schizophrenia here.

 

The Science Behind Schizophrenia

The exact processes of Schizophrenia are unknown, but momentous steps have been taken in determining exactly what causes this disorder and how the disorder actually affects the chemistry of the brain.

 

The various wnt pathways are depicted. Click here to read more about these schematics. 

 

One pathway that is implicated to have a major role in understanding schizophrenia is the Wnt signaling pathway. The Wnt signaling pathway is dependent on a Wnt ligand binding to its receptor so to promote the proteins APC and Disheveled to gather and dissociate the glycogen synthase kinase 3 b (GSK3b), which is a destruction complex targeted at keeping b-catenin phosphorylated. b-catenin maintaining its phosphorylated state leads to the decease in concentration of cytosolic b-catenin, which ultimately affects the initiation of T-cell factor/lymphoid enhancing factor (TCF/LEF)-mediated gene transcription.

 

 

 

 

 

The Stress of Remembering – PTSD and the Science Behind the Unforgettable

When we think of making everlasting memories, we often think of “the good” –  road trips with friends, victories at athletic contests, adventuresome family vacations. If you’ve had such experiences, then recollecting these memories is likely to bring a smile to your face. But what happens when “the bad” becomes unforgettable? What happens when traumatic events or negative experiences become so ingrained in memory that day-to-day living becomes difficult? This is the reality for nearly 8 million adults every year, who suffer from a mental illness called post traumatic stress disorder (known as PTSD). There is no way to predict when trauma will happen, and for this reason there are no reliable ways to prevent the disease. Likewise, there are currently no end-all cures or treatments for this debilitating disorder, and the reason why some people develop PTSD and others don’t is still a scientific mystery. Nonetheless, recent research has shown some light on the ominous world of PTSD. In a world where people are exposed to war, crimes, and a variety of not-so-great experiences, finding new ways to help, support, and treat victims must begin with the basics – understanding the science behind what is unforgettable.

 

PTSD – A Mental Battlefield

One of the most relevant examples of PTSD in today’s world is the story of the returning soldier. The soldier returns after war overseas, reunites with family, and lives happily and safely at home for the rest of his life, right? Unfortunately, we are all too familiar with the reality that follows. Instead of living happily ever after, the soldier is startled at the sound of a shutting door, grows anxious from the revving of a car engine, or is shocked by the explosive nature of fireworks on the Fourth of July. Though not present in all soldiers, PTSD has been found to impact a notable portion of veterans, police, and first responders (all careers which can put someone in stressful situations). In essence, PTSD is a mental disorder that is triggered by either witnessing or experiencing an extremely stressful or traumatic event, such as warfare. Symptoms and implications vary in intensity, but among some of the most notable are:

  • Severe anxiety
  • Flashbacks, or reliving the event
  • Unwanted memories of event
  • Nightmares or dreams
  • Avoidance of situations or discussions that might serve as reminders
  • Some degree of depression, detachment, or feeling numb
  • Insomnia
  • Irritability
  • Hypervigilance, being easily startled or frightened by “normal” events, sounds, images, etc (also called “stimulus generalization”)

Though PTSD patients often share similar symptoms as those with other stress and anxiety disorders, PTSD has recently been identified as its own “category” of mental disorders. For a full list of symptoms, risk factors, and advice on working with PTSD patients, visit, you can visit the Mayo Clinic webpage here.

Sufferers of PTSD often experience relationship problems and self-destructive behavior that interferes with daily life. It is often hard for victims to think about anything else, let alone anything positive. At this point, stress becomes pathological. Despite its severe implications, little is known in terms of how this stress disorder manifests itself in the human brain. What do the scientists think? Keep reading to find out!

 

When Memory Becomes Pathology

It’s very easy to get lost in the weeds of behavioral and psychological aspects of PTSD, but like every other mental illness, PTSD must start with a change in the brain. A quick read of this recent review paper offers potential explanations for a variety of factors that might contribute to such changes. The subjects can be quite confusing, and it can be hard to imagine how each piece fits into the big picture. It helps to keep one main question in mind when trying to describe such complicated processes:

What happens in the brain after a stressful event that turns a memory into pathologic symptoms?

We will begin by attempting to answer this question. Specifically, how does the brain change in response to stress, and why do such changes cause PTSD in some victims of trauma? To oversimplify things a bit, it boils down to mainly two things: epigenetics and gene expression

  • Gene expression refers to the process of converting DNA code into things (such as proteins and amino acids) our cells need to live, function, and carry out their specific tasks. Expressing different genes can lead to different outcomes or products.
  • Epigenetics refers to changes or modifications in a cell that can alter gene expression, without changing the original DNA code itself.

How does this relate to PTSD? Research suggests that stressful events cause epigenetic changes inside neurons (brain cells) that alter gene expression and thus their function – and ultimately the brain’s function. There are multiple elements that work together to cause this change.  A simplified proposed pathway of these elements is detailed below:

Stress Stress Hormones, Glutamate Release Epigenetic Change Changes in Glutamate Transmission Overexcitation, Changes in Learning, Brain Damage PTSD

Looks complicated, doesn’t it? Let’s break it down step by step.

Stress and Stress Hormones: The word that every adult can relate to. Stress often comes with negative associations, and in the case of PTSD it’s no different. In the brain, stressful events (especially acute, traumatic events) trigger the release of stress hormones. These hormones are called corticosteroids and glucocorticoids. In addition, an increase in the amount of an excitatory neurotransmitter called glutamate is observed. This neurotransmitter tends to excite neurons, which is part of the reason why we are often awake and alert during stress! These increases are seen especially in parts of the brain necessary for emotion, memory, and fear – the limbic system. Notable parts include:

  • Amygdala (fear, aggression, emotional learning)
  • Hippocampus (memory consolidation and formation)
  • Dentate Gyrus (part of the hippocampus, used when forming distinct memories)

 

Epigenetic Change: This step can be easiest understood by looking at a forced swim rat study. The test does essentially what it sounds like – it forces a rat to swim for a period of time. It serves as a means of eliciting a “traumatic” or stressful memory in a rat and seeing how the rat behaves afterwards. Essentially what happens is:

  • Rat placed in water, forced to swim
  • Rat grows stressed and frantically swims
  • After a while, the rat goes still (called the immobility response, or learned helplessness)
  • Rat is removed from water

    Just keep swimming, just keep swimming…

If the rat remembers this traumatic experience, then it will grow immobile in a shorter amount of time if placed in another forced swim test, having remembered what happened in the previous test. Interestingly, scientists found that an epigenetic change is responsible for the formation of this memory, and the development of the immobility response. Using a method called chromatin immunoprecipitation, or CHIP (not the edible kind), scientists were able to look at changes in chromatin (genetic material within cells) following a stressful event. The chemical change that literally “marked” the formation of this strong memory was found in a protein, called a histone (conveniently named H3s10KM), in the dentate gyrus. Here’s the chemical rundown:

  • Stress hormones bind to stress hormone receptors in brain cells, creating complexes
  • Meanwhile, glutamate interacts with its own receptors, called AMPA and NMDA receptors, normally important for long term memory formation. More basic information about this can be found here
  • Calcium moves into the cell through NMDA. This leads to chemical changes that activate a series of enzymes (called MEK and ERK, specifically – scientists are really good at giving names!)
  • ERK interacts with stress hormone receptor complexes
  • This interaction leads to a phosphate “on switch” being added to (you guessed it) more enzymes. The one we are interested in here is called Elk.
  • After being exposed to a particular electric signal from a brain cell (called p300, in response to the stressor), Elk adds a chemical group called an acetyl to the histone.
  • Adding an acetyl to this histone “opens” the cell’s DNA at some particular genes (formally known as immediate early genes), which makes it easier for them to be reached and expressed. These genes have been found to regulate stress responses.

Interestingly, using chemicals that block the development of this acetyl “mark” or made the patheay malfunction led to rats that panicked every time they were placed in a similar situation, similar to what is observed in PTSD patients. If you’re more of a visual learner, here’s a helpful figure from the text:

 

Changes in Glutamate Transmission and Brain Damage: Seems like quite the process doesn’t it? If you haven’t stressed yourself out reading about epigenetics yet, here’s what happens next. The particular function of these “exposed” genes isn’t exactly known, but it’s predicted that they can change glutamate release throughout the limbic system, and this might lead to higher levels of glutamate in these parts. If you read the article linked above, you’ll know that glutamate is normally considered “the good stuff” – it helps with learning via interaction with AMPA and NMDA receptors and getting neurons all fired up! Normally, glutamate helps learning by activating a process that recruits more AMPA receptors to neurons (in a region called a synapse, these are what we think of when we hear “neuron connections, but it’s actually an empty space!). These receptors make it easier for neurons to respond to incoming signals. This explains why rehearsing something over and over makes it easier to remember – your neurons respond more easily to an incoming stimulus! But like the mantra goes, too much of a good thing isn’t great. So what happens if there’s too much glutamate? In a nutshell:

  • Neurons may become overexcited
  • Too much glutamate accumulates and becomes toxic
  • Can promote epigenetic change, which messes with the gene expression mentioned above, enhancing the cycle and stress responses
  • Hyperactive recruitment of AMPA receptors may strengthen memory of the stressful event
  • Too much stimulation in the limbic system can lead to anxiety, insomnia
  • An overactive amygdala can “overwork” the hippocampus (which tries to “calm it down”), leading to damage in this area of the brain
  • Damage to the dentate gyrus leads to loss of ability to distinguish distinct memories from each other, which can lead to fear and anxiety from what we’d consider “normal” events
  • Symptoms of PTSD manifest

The bottom line: like most things in life, glutamate is best in moderation. At such dramatic levels, which can result from being exposed to a traumatic event, the making of a memory truly becomes a potentially harmful pathology.

 

Victory for Victims – Treatments for PTSD and the Future

Although we are far from finding an efficient, effective pharmacologic treatment for PTSD, the paper above details some existing research done on animal models to study behavior that stems from learning and memory. Studying the behavior of rats in response to administering specific drugs that target the mechanisms described previously offers us a look at what works and what doesn’t. Currently, drugs often used to treat other mental disorders can be used to treat the symptoms of PTSD. These include

  • Antidepressants
  • Anti-epilectic medication
  • Anti-anxiety medications
  • NMDA antagonists (only tested in the lab, and not safe for healthy individuals)

Sadly, there aren’t many approved medications for treating PTSD, due to the sheer number of undesirable side effects. The most successful modern treatment for PTSD is not chemical – it’s largely based on behavioral therapy. Research on animal models has even found that something as simple as exercise can lessen symptoms of this disorder! But having PTSD also doesn’t spell out the end. Many PTSD patients are able to improve their symptoms to some extent, and some even make significant steps towards full recovery. When brainstorming modes of prevention though, there is one big question that looms overhead…

How stressful does an experience have to BE to trigger PTSD?

The true answer is we don’t know – and we might never. Why do only some victims of trauma develop PTSD? We don’t know. Memory formation is an extremely complicated topic in itself, and how we respond to and perceive our memories varies from person to person, rat to rat. How the brain decides what is stressful enough to literally “leave a mark” and what is so insignificant we won’t even notice is beyond our understanding. The brain in itself, like PTSD, is a mysterious object in science. Nonetheless, how we act depends on what we remember.

Spam prevention powered by Akismet